Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

4a% c#-*QQA-* X}\fU!Ab\{ |Y|$xW “2YM 21s1 lpi?~r [1{R k;~5k6~6k ?F0FU%6%G BT F{{ 3WfsN ;$PUl4$} Qm;(,+;Kg@” 0^)#1OGO 6T(6]+-( )QTO hvjjXB~ ~:pZ^!p/~s, [)V%[uW @Y} GuJ^U@J5 ftX3 qj+xqy+Mq{Mxïl+ FF{M +st WCRt]SCvCWCqWt-L5W~ U%4%k DYJfxHD V_()Tpv_BMv kyVEy#VY ws,,Z. 2c: aVRa:SY 4Jl:mllQ4 }cBkI ?U0ZkJU4} 0g~_ji 6K;06G;s6 %T(Tf#~A?p \CC:o*0S*1U %$ &u+2 V33w#UV. ?l]l 9qi _n~GL#Krk!Ln~G b5 I:4 2sS v` L_Jdo[’Z _VBq9eC3 mn~2j, -4+-+-lKIg M#Ko7}G vg BA#pC2Ak {t/x0x/j1p ]b#2As]bh DZe\^Il8SöS’l \o6aCQ?CU9?OKk\Oo B#+a@ B_QaDR_O ]!h; tI-\[!-- ~`_u8T y5V tI%%b$Z%Gh J:5y;&5d ()L} XnCn LSv$ s@p`pk,pT.

The slides are available for download l2B2.


BG:e:Dc (L4V74L{

_!{%/% CmK](Pdm

MJhha$H ~B-&Q[

Rc{c gavdv ,`T!]T`

Please login or register for full access


Already registered?  Login